Proleukin (Prometheus Laboratories Inc.)
Welcome to the PulseAid listing for the Proleukin drug offered from Prometheus Laboratories Inc.. This Increased Lymphocyte Activation [PE],Increased Lymphocyte Cell Production [PE],Interleukin-2 [Chemical/Ingredient],Lymphocyte Growth Factor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Prometheus Laboratories Inc. |
NON-PROPRIETARY NAME: | aldesleukin |
SUBSTANCE NAME: | ALDESLEUKIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Increased Lymphocyte Activation [PE],Increased Lymphocyte Cell Production [PE],Interleukin-2 [Chemical/Ingredient],Lymphocyte Growth Factor [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 1992-05-05 |
END MARKETING DATE: | 0000-00-00 |
Proleukin HUMAN PRESCRIPTION DRUG Details:
Item Description | Proleukin from Prometheus Laboratories Inc. |
LABELER NAME: | Prometheus Laboratories Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1.1(mg/mL) |
START MARKETING DATE: | 1992-05-05 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 65483-116_b3294680-603d-42f9-a4c9-473213f6797a |
PRODUCT NDC: | 65483-116 |
APPLICATION NUMBER: | BLA103293 |
Other ALDESLEUKIN Pharmaceutical Manufacturers / Labelers: